80_FR_11497 80 FR 11456 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

80 FR 11456 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 41 (March 3, 2015)

Page Range11456-11456
FR Document2015-04328

Federal Register, Volume 80 Issue 41 (Tuesday, March 3, 2015)
[Federal Register Volume 80, Number 41 (Tuesday, March 3, 2015)]
[Notices]
[Page 11456]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-04328]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Immunobiology of 
Xenotransplantation (U01, U19).
    Date: March 23-24, 2015.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Room 3F100, 5601 Fishers 
Lane, Rockville, MD 20892, (Telephone Conference Call).
    Contact Person: Nancy Vazquez-Maldonado, Ph.D., Scientific 
Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700B 
Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, 301-496-3253, 
[email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Mucosal Environment and HIV 
Prevention (MEHP II (R01)).
    Date: March 23-24, 2015.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Room 3C100, 5601 Fishers 
Lane, Rockville, MD 20892, (Telephone Conference Call).
    Contact Person: Kelly Y. Poe, Ph.D., Scientific Review Officer, 
Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, 
Rockville, MD 20892, 240-669-5036, [email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Innovative Assays to Quantify the 
Latent HIV Reservoir (R01).
    Date: March 26, 2015.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Room 4F100, 5601 Fishers 
Lane, Rockville, MD 20892.
    Contact Person: Jay R Radke, Ph.D., AIDS Review Branch, 
Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 3G11B, 5601 
Fishers Lane, Rockville, MD 20892, 240-669-5046, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: February 25, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-04328 Filed 3-2-15; 8:45 am]
BILLING CODE 4140-01-P



                                                  11456                          Federal Register / Vol. 80, No. 41 / Tuesday, March 3, 2015 / Notices

                                                  Administration, 10903 New Hampshire                       Dated: February 24, 2015.                             Agenda: To review and evaluate grant
                                                  Ave., Silver Spring, MD 20993–                          Leslie Kux,                                           applications.
                                                  0002,Telephone: 301–796–1732, FAX:                                                                              Place: National Institutes of Health, Room
                                                                                                          Associate Commissioner for Policy.
                                                                                                                                                                4F100, 5601 Fishers Lane, Rockville, MD
                                                  301–796–9858, denise.picabranco@                        [FR Doc. 2015–04376 Filed 3–2–15; 8:45 am]            20892.
                                                  fda.hhs.gov.                                            BILLING CODE 4164–01–P                                  Contact Person: Jay R Radke, Ph.D., AIDS
                                                                                                                                                                Review Branch, Scientific Review Program,
                                                  SUPPLEMENTARY INFORMATION:      The first                                                                     DEA/NIAID/NIH/DHHS, Room 3G11B, 5601
                                                  day of the workshop will focus on                       DEPARTMENT OF HEALTH AND                              Fishers Lane, Rockville, MD 20892, 240–669–
                                                  approaches for assessing the efficacy of                HUMAN SERVICES                                        5046, jay.radke@nih.gov.
                                                  therapeutic products on neurocognitive                                                                        (Catalogue of Federal Domestic Assistance
                                                  outcomes in patients diagnosed with                     National Institutes of Health                         Program Nos. 93.855, Allergy, Immunology,
                                                  inborn errors of metabolism disorders.                                                                        and Transplantation Research; 93.856,
                                                  The session will address the role of                    National Institute of Allergy and                     Microbiology and Infectious Diseases
                                                                                                          Infectious Diseases; Notice of Closed                 Research, National Institutes of Health, HHS)
                                                  natural history studies and
                                                  methodological approaches for selecting                 Meetings                                                Dated: February 25, 2015.
                                                  appropriate assessment scales and                         Pursuant to section 10(d) of the                    David Clary,
                                                  standardizing neurocognitive                            Federal Advisory Committee Act, as                    Program Analyst, Office of Federal Advisory
                                                  assessments. The second day of the                      amended (5 U.S.C. App.), notice is                    Committee Policy.
                                                  workshop will discuss identification of                 hereby given of the following meetings.               [FR Doc. 2015–04328 Filed 3–2–15; 8:45 am]
                                                  signals in animal studies and clinical                    The meetings will be closed to the                  BILLING CODE 4140–01–P
                                                  trials that warrant further clinical                    public in accordance with the
                                                  investigation and testing that may be                   provisions set forth in sections
                                                  predictive of neurocognitive outcome in                 552b(c)(4) and 552b(c)(6), title 5 U.S.C.,            DEPARTMENT OF HEALTH AND
                                                  children. Additionally, strategies and                  as amended. The grant applications and                HUMAN SERVICES
                                                  methods to address the challenges of                    the discussions could disclose
                                                                                                                                                                National Institutes of Health
                                                  assessing long-term neurocognitive                      confidential trade secrets or commercial
                                                  outcomes for products used to treat                     property such as patentable material,                 Center for Scientific Review; Notice of
                                                  pediatric patients will be discussed.                   and personal information concerning                   Closed Meetings
                                                                                                          individuals associated with the grant
                                                  Participation in the Public Workshop                    applications, the disclosure of which                   Pursuant to section 10(d) of the
                                                                                                          would constitute a clearly unwarranted                Federal Advisory Committee Act, as
                                                     Registration: There is no fee to attend                                                                    amended (5 U.S.C. App.), notice is
                                                                                                          invasion of personal privacy.
                                                  the public workshop, but attendees                                                                            hereby given of the following meetings.
                                                  should register in advance. Space is                      Name of Committee: National Institute of              The meetings will be closed to the
                                                  limited, and registration will be on a                  Allergy and Infectious Diseases Special
                                                                                                          Emphasis Panel; Immunobiology of
                                                                                                                                                                public in accordance with the
                                                  first-come, first-served basis. Persons                 Xenotransplantation (U01, U19).                       provisions set forth in sections
                                                  interested in attending this workshop                     Date: March 23–24, 2015.                            552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
                                                  must register online at neurocognitive_                   Time: 9:00 a.m. to 6:00 p.m.                        as amended. The grant applications and
                                                  workshop@fda.hhs.gov before March 31,                     Agenda: To review and evaluate grant                the discussions could disclose
                                                  2015. For those without Internet access,                applications.                                         confidential trade secrets or commercial
                                                  please contact Denise Pica-Branco (see                    Place: National Institutes of Health, Room          property such as patentable material,
                                                  FOR FURTHER INFORMATION CONTACT) to                     3F100, 5601 Fishers Lane, Rockville, MD               and personal information concerning
                                                                                                          20892, (Telephone Conference Call).                   individuals associated with the grant
                                                  register. Onsite registration will not be                 Contact Person: Nancy Vazquez-
                                                  available.                                              Maldonado, Ph.D., Scientific Review Officer,
                                                                                                                                                                applications, the disclosure of which
                                                                                                          Scientific Review Program, DEA/NIAID/NIH/             would constitute a clearly unwarranted
                                                     If you need special accommodations
                                                                                                          DHHS, 6700B Rockledge Drive, MSC–7616,                invasion of personal privacy.
                                                  due to a disability, please contact
                                                  Denise Pica-Branco (see FOR FURTHER                     Bethesda, MD 20892–7616, 301–496–3253,                  Name of Committee: Center for Scientific
                                                                                                          nvazquez@niaid.nih.gov.                               Review Special Emphasis Panel; Program
                                                  INFORMATION CONTACT) at least 7 days in
                                                                                                            Name of Committee: National Institute of            Project: Structure/Function studies of
                                                  advance.
                                                                                                          Allergy and Infectious Diseases Special               Secondary Transporters in a Lipid
                                                     Transcripts: Transcripts of the                      Emphasis Panel; Mucosal Environment and               Environment.
                                                  workshop will be available for review at                HIV Prevention (MEHP II (R01)).                         Date: March 23–25, 2015.
                                                  the Division of Dockets Management                        Date: March 23–24, 2015.                              Time: 10:00 a.m. to 5:00 p.m.
                                                  (HFA–305), Food and Drug                                  Time: 12:00 p.m. to 4:00 p.m.                         Agenda: To review and evaluate grant
                                                                                                            Agenda: To review and evaluate grant                applications.
                                                  Administration, 5630 Fishers Lane, Rm.
                                                                                                          applications.                                           Place: National Institutes of Health, 6701
                                                  1061, Rockville, MD 20852, and at                         Place: National Institutes of Health, Room          Rockledge Drive, Bethesda, MD 20892,
                                                  http://www.regulations.gov                              3C100, 5601 Fishers Lane, Rockville, MD               (Virtual Meeting).
                                                  approximately 30 days after the                         20892, (Telephone Conference Call).                     Contact Person: Albert Wang, Scientific
                                                  workshop. A transcript will also be                       Contact Person: Kelly Y. Poe, Ph.D.,                Review Officer, Center for Scientific Review,
                                                  available in either hard copy or on CD–                 Scientific Review Officer, Scientific Review          National Institutes of Health, 6701 Rockledge
                                                  ROM, after submission of a Freedom of                   Program, DEA/NIAID/NIH/DHHS, 5601                     Drive, Room 4146, MSC 7806, Bethesda, MD
mstockstill on DSK4VPTVN1PROD with NOTICES




                                                  Information request. Send written                       Fishers Lane, Rockville, MD 20892, 240–669–           20892, 301–435–1016, wangca@csr.nih.gov.
                                                                                                          5036, Kelly.poe@nih.gov.                                Name of Committee: Center for Scientific
                                                  requests to the Division of Freedom of
                                                                                                            Name of Committee: National Institute of            Review Special Emphasis Panel; Member
                                                  Information (ELEM–1029), Food and
                                                                                                          Allergy and Infectious Diseases Special               Conflict: AIDS and AIDS Related Research.
                                                  Drug Administration, 12420 Parklawn                     Emphasis Panel; Innovative Assays to                    Date: March 24–25, 2015.
                                                  Dr., Element Bldg., Rockville, MD                       Quantify the Latent HIV Reservoir (R01).                Time: 10:00 a.m. to 5:00 p.m.
                                                  20857. Send faxed requests to 301–827–                    Date: March 26, 2015.                                 Agenda: To review and evaluate grant
                                                  9267.                                                     Time: 9:00 a.m. to 6:00 p.m.                        applications.



                                             VerDate Sep<11>2014   19:24 Mar 02, 2015   Jkt 235001   PO 00000   Frm 00070   Fmt 4703   Sfmt 4703   E:\FR\FM\03MRN1.SGM   03MRN1



Document Created: 2015-12-18 11:55:48
Document Modified: 2015-12-18 11:55:48
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMarch 23-24, 2015.
FR Citation80 FR 11456 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR